Fig. 3
From: Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
ROC analysis for models predicting IgAN remission status. (A) In the whole cohort (n = 213). (B) In patients with baseline eGFR ≥ 60 ml/min/1.73 m2 (n = 142). (C) In patients with baseline eGFR < 60 ml/min/1.73 m2 (n = 71). The blue line represents the model based on clinical data at biopsy alone; the red line represents the model based on the combination of clinical data and uNAG level at biopsy; the yellow line represents the model using baseline clinical data, uNAG level and MEST-C score. Clinical data were MAP, 24-hour proteinuria and eGFR